OPAF Follow-Up PSA: NIH CONSENSUS PANEL CONFIRMS EFFECTIVENESS OF TOTAL KNEE REPLACEMENT

Jeffrey S. Reznick

Description

Title:

OPAF Follow-Up PSA: NIH CONSENSUS PANEL CONFIRMS EFFECTIVENESS OF TOTAL KNEE REPLACEMENT

Creator:

Jeffrey S. Reznick

Date:

12/11/2003

Text:

The Orthotic and Prosthetic Assistance Fund (OPAF) offers the following
press release from the National Institutes of Health (NIH), as a
follow-up to OPAF's PSA of October 30 (also below) regarding the
December NIH consensus conference on total knee replacement.

OPAF PSAs to the O&P list help to fulfill OPAF's official representation
of O&P in community and philanthropic circles.

Sincerely and with warmest holiday wishes,

Jeff Reznick

Jeffrey S. Reznick, Ph.D.
Executive Director and Senior Research Fellow
Orthotic & Prosthetic Assistance Fund, Inc. (OPAF)
1666 K Street NW, Suite 440
Washington, DC 20006
Tel 202.223.8878
eFax 415.534.1857
Email <Email Address Redacted>
Web www.opfund.org

---

> ----- Original Message -----
> From: NIH OLIB (NIH/OD) < <Email Address Redacted> >
> To: < <Email Address Redacted> >
> Sent: Wednesday, December 10, 2003 2:58 PM
> Subject: NIH CONSENSUS PANEL CONFIRMS EFFECTIVENESS OF TOTAL KNEE
> REPLACEM ENT
>
>
> > U.S. Department of Health and Human Services
> >
> > NATIONAL INSTITUTES OF HEALTH
> >
> > NIH News
> >
> > NIH Office of the Director (OD)
> > <URL Redacted>
> >
> > Office of Medical Applications of Research (OMAR)
> > <URL Redacted>
> >
> > EMBARGOED FOR RELEASE
> > Wednesday, December 10, 2003
> > 2:00 p.m. ET
> >
> > Contact:
> > Kelli Marciel
> > 301-496-4819
> > <Email Address Redacted>
> >
> >
> > NIH CONSENSUS PANEL CONFIRMS EFFECTIVENESS OF TOTAL KNEE REPLACEMENT
> >
> > Panel calls for more research into racial, ethnic, and gender
> > disparities
> >
> > BETHESDA, MARYLAND -- A panel charged with reviewing all of the
> > available evidence on total knee replacement (TKR) today found that
> > for persons suffering from intractable and persistent knee pain and
> > disability, TKR surgery is a safe and cost-effective therapy that
> > restores mobility and alleviates discomfort. Over 20 years of
> > follow-up data indicate that the procedure is successful in the vast

> > majority of patients.
> >
> > The panel reported that there is clear evidence of racial, ethnic,
> > and
>
> > gender disparities in the provision of total knee replacements, as
> > there is for many other health care interventions, but the reasons
> > for
>
> > this are unclear. Physicians' beliefs about their patients, limited
> > familiarity with these procedures in minority communities, and
> > patient mistrust of the health care system may all have a role. The

> > consensus panel is calling for more research to determine the causes

> > of these disparities.
> >
> > TKR is not for everyone -- it's major elective surgery that carries

> > a variety of important risks, but it often offers dramatic relief
> > after other therapies fail, said the panel chair, orthopaedic
> > surgeon Dr. E. Anthony Rankin of Providence Hospital in Washington,
> > D.C. The panel emphasized that for patients considering TKR,
> > important factors to consider include surgeon and hospital volume
>
> > of TKRs performed, as these are associated with lower complication
> > rates. Dr. Rankin explained, Basically, the more they do, the
> > better they do it.
> >
> > Loosening of the implant is the main cause of failed total knee
> > prostheses that necessitate revision procedures, and that proper
> > alignment of the prosthesis is critical to minimizing long-term wear

> > and loosening of the implant. The panel noted that computer
> > navigation
>
> > may eventually reduce the risk of substantial malalignment, but the
> > technology is as yet unproven and its cost may be prohibitive for
> > many hospitals.
> >
> > These findings are part of the panel's consensus statement,
> > presented at the close of this three-day consensus development
> > conference. The NIH Office of Medical Applications of Research
> > (OMAR) and the National
>
> > Institute of Arthritis and Musculoskeletal and Skin Diseases
> > (NIAMS), components of the U.S. Department of Health and Human
> > Services, sponsored the conference. Cosponsors included the
> > National Institute of Child Health and Human Development (NICHD),
> > the U.S. Food and Drug Administration (FDA), the National Institute
> > of Standards and Technology
> > (NIST) and the NIH Office of Research on Women's Health.
> >
> > The 11-member panel included practitioners and researchers in
> > orthopaedics, rheumatology, internal medicine, nursing, physical
> > therapy, rehabilitation, biostatistics, epidemiology, and health
> > services research, as well as a TKR patient. The conference brought

> > together experts in a range of relevant disciplines to present the
> > latest research in current TKR practice and outcomes to the
> > consensus panel. The panel reviewed an extensive collection of
> > medical literature related to TKR, including a systematic literature

> > review prepared by the Minnesota Evidence-Based Practice Center,
> > under contract with the Agency for Healthcare Research and Quality
> > (AHRQ). A summary of the Evidence Report on Total Knee Replacement
> > is available at <URL Redacted>. The full
> > report will be available on-line shortly.
> >
> > The panel's statement is an independent report and is not a policy
> > statement of the NIH or the Federal Government. The NIH Consensus
> > Development Program, of which this conference is a part, was
> > established in 1977 as a mechanism to judge controversial topics in
> > medicine and public health in an unbiased, impartial manner. NIH
> > has conducted 117 consensus development conferences, and 22
> > state-of-the- science (formerly technology assessment)
> > conferences, addressing a wide range of issues.
> >
> > The full text of the panel's statement will be available in draft
> > form
>
> > following the conference at http://consensus.nih.gov . The final
> > version will be available at the same web address in three to four
> > weeks. Statements from past conferences and additional information
> > about the NIH Consensus Development Program are also available at
> > the Web site, or by calling 1-888-644-2667.
> >
> > The archived videocast of the conference sessions will be available
> > shortly at http://consensus.nih.gov/ .
> >
> > NOTE TO RADIO EDITORS: An audio report of the conference results
> > will be available after 4 p.m. December 10, 2003 from the NIH Radio
> > News Service by calling 1-800-MED-DIAL (1-800-633-3425).
> >
> >
> > ##

-----Original Message-----
From: Sharon Schultz [mailto:<Email Address Redacted>]
Sent: Thursday, October 30, 2003 4:22 PM
To: <Email Address Redacted>
Subject: NIH Consensus Conference Update

The Office of Medical Applications of Research (OMAR) and the National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),
National Institutes of Health (NIH) are convening a consensus
development conference to explore and assess current scientific
knowledge regarding total knee replacement (TKR).

With the number of TKR surgeries performed each year increasing and
indications for TKR extending to younger patients, this landmark
conference will serve as a forum to enhance clinical decision-making and
stimulate further research.
The NIH Consensus Development Conference
on Total Knee Replacement
will be held December 8 - 10 at the NIH campus in
Bethesda, Maryland.

There is no charge for attendance, but registration is limited!

The NIH/FAES is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for
physicians.

The NIH/FAES designates this educational activity for a maximum of 12.5
category 1 credits toward the AMA Physician's Recognition Award. Each
physician should claim only those credits that he/she actually spent in
the activity. Please see below for additional information pertaining to
CME.

To be certain that we reach everyone who will want to be on hand for
this significant conference, we would appreciate your sharing
information about this conference. Please send this information to your
listservs and include it in any internal and external communication
vehicles to assure colleagues and associates get the word! You can view
the online registration form, detailed logistics, and updates to the
agenda at: http://consensus.nih.gov .

Join a distinguished gathering of medical practitioners and allied
health field representatives; researchers, scientists, and physical
therapists; medical device manufacturers and researchers; insurers and
providers; professional organizations and associations; and key
stakeholders, including consumers, in this important national dialogue.

To obtain a conference web banner for your web site, please reply to
this email.

We appreciate your support!
Sincerely,

Kelli Marciel, MA
Communications Director
NIH Consensus Development Program
Office of the Director, NIH

This conference is intended for health care practitioners and
researchers with any of the following interests or specialties:
orthopedic surgery, geriatrics, sports medicine, physical therapy,
rheumatology, as well as general practitioners.

The CME educational objective for this activity is to enable
participants to recognize how the preponderance of available evidence
should inform current practice and future research in total knee
replacement.

Sign language interpretation will be provided. Individuals with
disabilities who need accommodations to participate in this event should
call 1-888-644-2667.

For additional information on event faculty, please visit
http://consensus.nih.gov or phone 1-888-644-2667.

                          

Citation

Jeffrey S. Reznick, “OPAF Follow-Up PSA: NIH CONSENSUS PANEL CONFIRMS EFFECTIVENESS OF TOTAL KNEE REPLACEMENT,” Digital Resource Foundation for Orthotics and Prosthetics, accessed November 6, 2024, https://library.drfop.org/items/show/222197.